This p53/miR-519d negative feedback loop influenced both proliferation and invasion capabilities of HCC cells as well as their response to chemotherapy and molecular targeted therapy, therefore contributing to the malignant phenotype of HCC [78]. This evidence concerns the gene TP53 and hepatocellular carcinoma.